Related Experiment Video
Updated: Oct 5, 2025

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
Cerebrospinal Fluid Biomarkers, Brain Structural and Cognitive Performances Between Normotensive and Hypertensive
Atef Badji1,2,3, Joana B Pereira3, Sara Shams4,5,6
1NeuroPoly Lab, Institute of Biomedical Engineering, Polytechnique Montréal, Montréal, QC, Canada.
Insights
Hypertension is linked to increased cerebrovascular damage, not Alzheimer's disease pathology, in older adults. Managing blood pressure may prevent brain vascular issues and subsequent cognitive decline.
Area of Science:
- Neurology
- Gerontology
- Cardiology
Background:
- Hypertension is a known risk factor for Alzheimer's disease (AD), potentially involving microvascular dysfunction.
- Previous research has explored hypertension's impact on brain integrity markers.
- A comprehensive comparison of cerebrospinal fluid (CSF) biomarkers and brain structure differences between normotensive and hypertensive older adults concerning cognitive performance is lacking.
Purpose of the Study:
- To investigate cognitive performance, CSF biomarkers, and brain structure differences in normotensive, controlled hypertensive, uncontrolled hypertensive, and untreated hypertensive older adults.
- To compare markers of vascular brain pathology and AD pathology/neurodegeneration across different blood pressure groups.
- To assess the relationship between these markers and cognitive functions.
Main Methods:
- Magnetic resonance imaging (MRI) to measure white matter hyperintensities (WMHs), lacunes, cerebral microbleeds, enlarged perivascular spaces (epvs), fractional anisotropy (FA), hippocampal volume, and temporal cortical thickness.
- Cerebrospinal fluid (CSF) analysis for amyloid-β42, phosphorylated tau, and neurofilament light protein (NfL).
- Neuropsychological tests to evaluate memory, attention, processing speed, executive function, verbal fluency, and visuospatial abilities.
Main Results:
- Hypertensive participants exhibited greater white matter pathology (lower FA, more WMHs, epvs) compared to normotensive individuals, with the highest burden in uncontrolled hypertensive groups.
- No significant differences were observed in MRI or CSF markers of AD pathology/neurodegeneration between normotensive and hypertensive groups, or among hypertensive subgroups.
- Most cognitive functions did not differ significantly between the groups.
Conclusions:
- Effective blood pressure control may prevent cerebrovascular pathology.
- Hypertension might contribute to cognitive decline primarily through its impact on cerebrovascular pathology, rather than AD-related pathology.
- Hypertension is associated with MRI markers of vascular pathology, even without significant cognitive decline.
Abstract:
Background: Hypertension is an important risk factor for Alzheimer's disease (AD). The pathophysiological mechanisms underlying the relationship between AD and hypertension are not fully understood, but they most likely involve microvascular dysfunction and cerebrovascular pathology. Although previous studies have assessed the impact of hypertension on different markers of brain integrity, no study has yet provided a comprehensive comparison of cerebrospinal fluid (CSF) biomarkers and structural brain differences between normotensive and hypertensive groups in a single and large cohort of older adults in relationship to cognitive performances. Objective: The aim of the present work was to investigate the differences in cognitive performances, CSF biomarkers and magnetic resonance imaging (MRI) of brain structure between normotensive, controlled hypertensive, uncontrolled hypertensive, and untreated hypertensive older adults from the Gothenburg H70 Birth Cohort Studies. Methods: As an indicator of vascular brain pathology, we measured white matter hyperintensities (WMHs), lacunes, cerebral microbleeds, enlarged perivascular space (epvs), and fractional anisotropy (FA). To assess markers of AD pathology/neurodegeneration, we measured hippocampal volume, temporal cortical thickness on MRI, and amyloid-β42, phosphorylated tau, and neurofilament light protein (NfL) in cerebrospinal fluid. Various neuropsychological tests were used to assess performances in memory, attention/processing speed, executive function, verbal fluency, and visuospatial abilities. Results: We found more white matter pathology in hypertensive compared to normotensive participants, with the highest vascular burden in uncontrolled participants (e.g., lower FA, more WMHs, and epvs). No significant difference was found in any MRI or CSF markers of AD pathology/neurodegeneration when comparing normotensive and hypertensive participants, nor among hypertensive groups. No significant difference was found in most cognitive functions between groups. Conclusion: Our results suggest that good blood pressure control may help prevent cerebrovascular pathology. In addition, hypertension may contribute to cognitive decline through its effect on cerebrovascular pathology rather than AD-related pathology. These findings suggest that hypertension is associated with MRI markers of vascular pathology in the absence of a significant decline in cognitive functions.
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension and Regulation of Blood Pressure
Hypertension I: Introduction
Cognitive Development During Adulthood
Cerebrospinal Fluid
CSF Production
CSF is produced mainly in the choroid plexus, a network of capillaries and ependymal cells located within the ventricular system of the brain....
Neural Regulation of Blood Pressure
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...

